SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001469709-15-000271
Filing Date
2015-05-19
Accepted
2015-05-19 15:03:49
Documents
4
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 ENDV 10-Q 03/31/15 endv10q_033115apg.htm 10-Q 364831
2 GRAPHIC endv10q_033115apg001.jpg GRAPHIC 38214
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 10774
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3918
  Complete submission text file 0001469709-15-000271.txt   433600
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-176954 | Film No.: 15876119
SIC: 2834 Pharmaceutical Preparations